Format
Sort by
Items per page

Send to

Choose Destination

Best matches for depressive disorder AND depressive disorder, major AND elderly AND unipolar depression:

Search results

Items: 1 to 20 of 22203

1.

Adolescent Major Depressive Disorder: Neuroimaging Evidence of Sex Difference during an Affective Go/No-Go Task.

Chuang JY, Hagan CC, Murray GK, Graham JME, Ooi C, Tait R, Holt RJ, Elliott R, van Nieuwenhuizen AO, Bullmore ET, Lennox BR, Sahakian BJ, Goodyer IM, Suckling J.

Front Psychiatry. 2017 Jul 11;8:119. doi: 10.3389/fpsyt.2017.00119. eCollection 2017.

2.

Effects of a Course of Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy Combined With Venlafaxine on Insomnia Symptoms in Elderly Depressed Patients.

McCall WV, Lisanby SH, Rosenquist PB, Dooley M, Husain MM, Knapp RG, Petrides G, Rudorfer MV, Young RC, McClintock SM, Mueller M, Prudic J, Greenberg RM, Weiner RD, Bailine SH, Riley MA, McCloud L, Kellner CH; CORE/PRIDE Work Group.

J Clin Psychiatry. 2017 Jul 18. pii: 16m11089. doi: 10.4088/JCP.16m11089. [Epub ahead of print]

PMID:
28742292
3.

Apathy in early and late-life depression.

Groeneweg-Koolhoven I, Ploeg M, Comijs HC, Wjh Penninx B, van der Mast RC, Schoevers RA, Rhebergen D, Exel EV.

J Affect Disord. 2017 Jul 10;223:76-81. doi: 10.1016/j.jad.2017.07.022. [Epub ahead of print]

PMID:
28734148
4.

Effectiveness of the management of major depressive episodes/disorder in adults with comorbid chronic physical diseases: a protocol for a systematic review and meta-analysis.

Martínez P, Castro A, Alonso D, Vöhringer PA, Rojas G.

BMJ Open. 2017 Jul 20;7(7):e011249. doi: 10.1136/bmjopen-2016-011249.

5.

The association between multiple chemical sensitivity and mental illness: Evidence from a nationally representative sample of Canadians.

Johnson D, Colman I.

J Psychosom Res. 2017 Aug;99:40-44. doi: 10.1016/j.jpsychores.2017.06.002. Epub 2017 Jun 8.

PMID:
28712429
6.

Problem alcohol use and healthcare utilization among persons with cannabis use disorder in the United States.

John WS, Wu LT.

Drug Alcohol Depend. 2017 Jun 30;178:477-484. doi: 10.1016/j.drugalcdep.2017.05.035. [Epub ahead of print]

PMID:
28711814
7.

Partially distinct combinations of psychological, metabolic and inflammatory risk factors are prospectively associated with the onset of the subtypes of Major Depressive Disorder in midlife.

Rudaz DA, Vandeleur CL, Gebreab SZ, Gholam-Rezaee M, Strippoli MF, Lasserre AM, Glaus J, Castelao E, Pistis G, von Känel R, Marques-Vidal P, Waeber G, Vollenweider P, Preisig M.

J Affect Disord. 2017 Nov;222:195-203. doi: 10.1016/j.jad.2017.07.016. Epub 2017 Jul 8.

PMID:
28710953
8.

Comparative Benefits and Harms of Complementary and Alternative Medicine Therapies for Initial Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis.

Asher GN, Gartlehner G, Gaynes BN, Amick HR, Forneris C, Morgan LC, Coker-Schwimmer E, Boland E, Lux LJ, Gaylord S, Bann C, Pierl CB, Lohr KN.

J Altern Complement Med. 2017 Jul 12. doi: 10.1089/acm.2016.0261. [Epub ahead of print]

PMID:
28700248
9.

Posttraumatic stress disorder: a serious post-earthquake complication.

Farooqui M, Quadri SA, Suriya SS, Khan MA, Ovais M, Sohail Z, Shoaib S, Tohid H, Hassan M.

Trends Psychiatry Psychother. 2017 Apr-Jun;39(2):135-143. doi: 10.1590/2237-6089-2016-0029.

10.

Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial.

Mohamed S, Johnson GR, Chen P, Hicks PB, Davis LL, Yoon J, Gleason TC, Vertrees JE, Weingart K, Tal I, Scrymgeour A, Lawrence DD, Planeta B, Thase ME, Huang GD, Zisook S; and the VAST-D Investigators, Rao SD, Pilkinton PD, Wilcox JA, Iranmanesh A, Sapra M, Jurjus G, Michalets JP, Aslam M, Beresford T, Anderson KD, Fernando R, Ramaswamy S, Kasckow J, Westermeyer J, Yoon G, D'Souza DC, Larson G, Anderson WG, Klatt M, Fareed A, Thompson SI, Carrera CJ, Williams SS, Juergens TM, Albers LJ, Nasdahl CS, Villarreal G, Winston JL, Nogues CA, Connolly KR, Tapp A, Jones KA, Khatkhate G, Marri S, Suppes T, LaMotte J, Hurley R, Mayeda AR, Niculescu AB 3rd, Fischer BA, Loreck DJ, Rosenlicht N, Lieske S, Finkel MS, Little JT.

JAMA. 2017 Jul 11;318(2):132-145. doi: 10.1001/jama.2017.8036.

PMID:
28697253
11.

Genome-wide association studies of placebo and duloxetine response in major depressive disorder.

Maciukiewicz M, Marshe VS, Tiwari AK, Fonseka TM, Freeman N, Kennedy JL, Rotzinger S, Foster JA, Kennedy SH, Müller DJ.

Pharmacogenomics J. 2017 Jul 11. doi: 10.1038/tpj.2017.29. [Epub ahead of print]

PMID:
28696415
12.

White matter correlates of impaired attention control in major depressive disorder and healthy volunteers.

Rizk MM, Rubin-Falcone H, Keilp J, Miller JM, Sublette ME, Burke A, Oquendo MA, Kamal AM, Abdelhameed MA, Mann JJ.

J Affect Disord. 2017 Nov;222:103-111. doi: 10.1016/j.jad.2017.06.066. Epub 2017 Jun 30.

PMID:
28688263
13.

Affective and cognitive theory of mind abilities in youth with borderline personality disorder or major depressive disorder.

Tay SA, Hulbert CA, Jackson HJ, Chanen AM.

Psychiatry Res. 2017 Jun 23;255:405-411. doi: 10.1016/j.psychres.2017.06.016. [Epub ahead of print]

PMID:
28667928
14.

Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder.

Cha DS, Carmona NE, Subramaniapillai M, Mansur RB, Lee Y, Hon Lee J, Lee J, Rosenblat JD, Shekotikhina M, Park C, Rong C, Greer TL, Lam R, Baune BT, Harrison J, McIntyre RS.

J Affect Disord. 2017 Nov;222:14-20. doi: 10.1016/j.jad.2017.06.036. Epub 2017 Jun 23.

PMID:
28667888
15.

Low-dose ketamine for treatment resistant depression in an academic clinical practice setting.

Feifel D, Malcolm B, Boggie D, Lee K.

J Affect Disord. 2017 Oct 15;221:283-288. doi: 10.1016/j.jad.2017.06.043. Epub 2017 Jun 20.

PMID:
28666206
16.

Attentional bias scores in patients with depression and effects of age: a controlled, eye-tracking study.

Lu S, Xu J, Li M, Xue J, Lu X, Feng L, Fu B, Wang G, Zhong N, Hu B.

J Int Med Res. 2017 Jan 1:300060517708920. doi: 10.1177/0300060517708920. [Epub ahead of print]

PMID:
28661268
17.

Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.

Brunoni AR, Moffa AH, Sampaio-Junior B, Borrione L, Moreno ML, Fernandes RA, Veronezi BP, Nogueira BS, Aparicio LVM, Razza LB, Chamorro R, Tort LC, Fraguas R, Lotufo PA, Gattaz WF, Fregni F, Benseñor IM; ELECT-TDCS Investigators.

N Engl J Med. 2017 Jun 29;376(26):2523-2533. doi: 10.1056/NEJMoa1612999.

PMID:
28657871
18.

How effective is algorithm-guided treatment for depressed inpatients? Results from the randomized controlled multicenter German Algorithm Project 3 trial.

Adli M, Wiethoff K, Baghai TC, Fisher R, Seemüller F, Laakmann G, Brieger P, Cordes J, Malevani J, Laux G, Hauth I, Möller HJ, Kronmüller KT, Smolka MN, Schlattmann P, Berger M, Ricken R, Stamm TJ, Heinz A, Bauer M.

Int J Neuropsychopharmacol. 2017 Jun 22. doi: 10.1093/ijnp/pyx043. [Epub ahead of print]

PMID:
28645191
19.

Discrepancy between objective and subjective cognition in adults with major depressive disorder.

Srisurapanont M, Suttajit S, Eurviriyanukul K, Varnado P.

Sci Rep. 2017 Jun 20;7(1):3901. doi: 10.1038/s41598-017-04353-w.

20.

Polygenic risk for depression and the neural correlates of working memory in healthy subjects.

Yüksel D, Dietsche B, Forstner AJ, Witt SH, Maier R, Rietschel M, Konrad C, Nöthen MM, Dannlowski U, Baune BT, Kircher T, Krug A.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jun 15;79(Pt B):67-76. doi: 10.1016/j.pnpbp.2017.06.010. [Epub ahead of print]

PMID:
28624581

Supplemental Content

Loading ...
Support Center